AI Hub - The Medical Brick
Screening Hub offers an AI-based platform for cell screening in drug development, aiming to accelerate the process by making it faster, cheaper, better, and less risky. Their solution leverages deep learning for a wide range of cell screening applications, with a modular structure adaptable to various technical tasks and medical fields. Key features include extreme speed for faster results, interface independence, extreme scalability, and improved success rates by predicting toxicity and efficacy early. The company addresses challenges in drug development such as high costs, lengthy timelines, and the risk of false positives by providing automated analysis and evaluation of pharmacological effects, regardless of cell types. Their platform supports High Throughput Screening (HTS) using Spinning Disk Confocal Microscopy (SDCM) images and can analyze a significantly higher number of drug candidates compared to manual methods.
AI Hub - The Medical Brick
Screening Hub offers an AI-based platform for cell screening in drug development, aiming to accelerate the process by making it faster, cheaper, better, and less risky. Their solution leverages deep learning for a wide range of cell screening applications, with a modular structure adaptable to various technical tasks and medical fields. Key features include extreme speed for faster results, interface independence, extreme scalability, and improved success rates by predicting toxicity and efficacy early. The company addresses challenges in drug development such as high costs, lengthy timelines, and the risk of false positives by providing automated analysis and evaluation of pharmacological effects, regardless of cell types. Their platform supports High Throughput Screening (HTS) using Spinning Disk Confocal Microscopy (SDCM) images and can analyze a significantly higher number of drug candidates compared to manual methods.